Next Article in Journal
Heterogeneity of Multiple System Atrophy: An Update
Next Article in Special Issue
The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives
Previous Article in Journal
Human Serum Proteins and Susceptibility of Acinetobacter baumannii to Cefiderocol: Role of Iron Transport
Previous Article in Special Issue
Obesity Reshapes the Microbial Population Structure along the Gut-Liver-Lung Axis in Mice
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Drosophila Model for Studying Gut Microbiota in Behaviors and Neurodegenerative Diseases

1
Graduate Institute of Biomedical Sciences, Department of Biochemistry, Department of Microbiology, Department of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
2
Research and Development Department, GenMont Biotech Incorporation, Tainan 74144, Taiwan
3
Department of Neurology, Molecular Infectious Disease Research Center, Department of Pediatrics, Linkou Chang Gung Memorial Hospital, Taoyuan 33305, Taiwan
4
Department of Neurology, New Taipei Municipal Tucheng Hospital, Tucheng 23652, Taiwan
5
Department of Neurology, Xiamen Chang Gung Hospital, Xiamen 361028, China
6
Department of Medical Research, Graduate Institute of Biomedical Sciences, China Medical University and Hospital, Taichung 40402, Taiwan
7
Department of Nursing, Asia University, Taichung 41354, Taiwan
8
Brain Research Center, National Tsing Hua University, Hsinchu 30013, Taiwan
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomedicines 2022, 10(3), 596; https://doi.org/10.3390/biomedicines10030596
Submission received: 7 February 2022 / Revised: 1 March 2022 / Accepted: 1 March 2022 / Published: 3 March 2022
(This article belongs to the Special Issue Microbial Ecology in Health and Disease 2.0)

Abstract

:
Mounting evidence indicates that the gut microbiota is linked to several physiological processes and disease development in mammals; however, the underlying mechanisms remained unexplored mostly due to the complexity of the mammalian gut microbiome. The fruit fly, Drosophila melanogaster, is a valuable animal model for studying host-gut microbiota interactions in translational aspects. The availability of powerful genetic tools and resources in Drosophila allowed the scientists to unravel the mechanisms by which the gut microbes affect fitness, health, and behavior of their hosts. Drosophila models have been extensively used not only to study animal behaviors (i.e., courtship, aggression, sleep, and learning & memory), but also some human related neurodegenerative diseases (i.e., Alzheimer’s disease and Parkinson’s disease) in the past. This review comprehensively summarizes the current understanding of the gut microbiota of Drosophila and its impact on fly behavior, physiology, and neurodegenerative diseases.

1. Introduction

The fruit fly, Drosophila melanogaster, is an important experimental animal used in biomedical studies. The fruit fly was first used as an experimental organism by Castle in 1901 and Morgan in 1909 for genetic studies. Since Drosophila has been used as a model organism for over a century, several techniques have been developed to address specific scientific questions. Drosophila has a relatively short lifespan and complex behaviors. The availability of powerful tools for genetic manipulation in specific tissues or organs allowed the scientists to study the molecular mechanisms regulating Drosophila behavior, such as adaptive response to the surrounding environment, as well as innate (courtship, aggression, sleep, etc.) [1,2,3] and learned behaviors (olfactory memory and courtship memory) [4,5,6].
Over the past 20 years, Drosophila has been used as an ideal in vivo model for studying neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD) [7,8]. The prominent signaling pathways that regulate neuronal growth and functions in humans are conserved in Drosophila, allowing to use of this model organism for studying human neurodegenerative diseases. For example, the Drosophila model of AD developed by ectopically expressing human Aβ42 protein in the fly brain exhibits clinical symptoms associated with AD patients, such as age-dependent short-term memory impairment, learning defects, increased wakefulness, and sleep disruption [8,9]. This suggests that Drosophila can be used as an ideal in vivo model for screening novel drugs for the treatment of AD.
Mounting evidence supports the notion that a well-balanced gut microbiota is essential to human health [10,11]. Interfering with the composition of the gut microbiota may adversely affect the host health and physiology, leading to various neurological diseases, such as behavioral abnormalities, neurodegenerative diseases, and neuropsychiatric disorders [12,13,14]. Studies showed that the gut bacteria can produce several neurotransmitters, including dopamine, gamma-aminobutyric acid (GABA), and serotonin [15]. Moreover, the bidirectional crosstalk between the intestine and the central nervous system (CNS) is mediated through the gut microbiota [16,17]. Recent studies have indicated that alterations in the gut microbiota composition are related to certain neurological diseases [18,19,20]. However, the detailed mechanism of how intestinal bacteria regulate disease progression by influencing the communication along the gut-brain axis requires further investigation.
Over the past 20 years, most of the gut microbiota studies employed rodent models to investigate the role of the microbiota−gut-brain axis. However, the versatile organism, Drosophila, is a powerful research model that allows scientists to investigate the mechanisms by which gut microbes affect the brain functions (Figure 1a,b). The microbes can be genetically tagged with a fluorescent protein, thus, their distribution in the digestive tract of Drosophila can be visualized (Figure 1c) [21,22].

2. Drosophila Innate Behaviors

Innate behaviors are believed to be hardwired in the animal brain and genetically encoded, and require no prior experience for proper execution. Innate behaviors are highly adaptable to the internal state of animals and the external environment, which allows animals to modify their behaviors according to different environmental conditions [23]. Drosophila is an excellent animal model for studying the molecular mechanisms of human innate behaviors, since there are some similarities of behavioral phenotypes between flies and human. In Drosophila, a variety of innate behaviors have been studied, such as mating behavior, aggressive behavior, sleep/locomotor activity, and temperature-related behavior [3,24,25,26,27,28]. In addition, the Drosophila genome is around 60% homologous to that of human and approximately 75% of the human disease-related genes also have homologs in flies [29]. For example, in sleep behavior, the dopamine signaling regulates the wakefulness not only in Drosophila, but also in humans [30]. Herein, we introduce some crucial Drosophila innate behaviors, and discuss their relationship with the gut microbiota (Table 1).

2.1. Gut Microbiota and Mating Behavior

Mating behavior in male Drosophila includes a series of steps: progression towards the female (orientation), chasing the female (following), touching the female’s abdomen (tapping), unilateral wing extension and vibration (singing), licking the female’s genitalia, grasping up to the female’s back (attempted copulation), and final copulation [3,26]. One male fly attempts to mate with one virgin female, and the measurement of the male fly’s sexual enthusiasm towards the female is called the courtship index (CI). CI is the time spent by the male Drosophila on courtship divided by the total time of the experiment. The well-known neural circuit that regulates mating behavior is composed of fruitless (fru)-expressing neurons. The fru-expressing neurons including primary sensory afferents and central interneurons, such as P1 cluster neurons that trigger courtship, may form the core portion of the male courtship circuit [50].
At least three studies have reported that the gut microbiota does not affect courtship behavior in Drosophila [33,35,51]; however, it should be noted that each study used different wild-type flies and employed different methods to generate germ-free flies. Contrary to these studies, Heys et al. showed that the gut microbiota counteracts the male outbreeding strategy by altering the female sexual signaling, which leads to reduced sperm transfer from male flies [31]. Outbreeding in Drosophila increases genetic diversity in the offspring, enhances the immune defense, and may be affected by the host microbiota [31,52]. A previous study showed that 1- and 3-days post-mating, the gene expression pattern in the fly head tissue is altered, which affects fly behavior, including feeding behavior, metabolism, and egg production (post-mating behavior) [53]. Delbare et al. performed a large-scale RNA-seq analysis of virgin and mated axenic/conventional flies, and reported that, in mated females, the transcripts involved in regulating reproduction and neuronal functions are differentially abundant depending on the microbiota of females [32]. Moreover, the microbiota status of the male affected fecundity in both conventional and axenic females; however, it affected the transcriptional profiles only in axenic, but not in conventional, females.

2.2. Gut Microbiota and Aggressive Behavior

Aggressive behavior, which is widely observed in the animal kingdom, is critical for survival and reproduction [54]. In Drosophila, aggressive behavior includes wing threat, boxing, tapping with the front leg, lunging, and head butting [2,33]. Jia et al. described a protocol to analyze aggressive behavior in flies. In this assay, two male or female flies (5–7 days old) are placed in a fighting chamber, which is then rapidly covered with a 20 mm × 20 mm glass coverslip. The fight during the 30 min is recorded using a camera. Aggressive behavior is analyzed by counting the number of lunges in males and head butting in females, and evaluating the lunging frequency/fighting latency. Lunging frequency is defined as the number of lunges per minute after lunging initiation, whereas fighting latency is defined as the duration between the beginning of the recording and the first lunging [33]. Studies suggest that aggressive behaviors coordinate with visual, olfactory, gustatory, mechanosensory, and auditory inputs. These inputs integrate into the brain mushroom body (MB), lateral horn, and central complex regions, and finally drive the motor outputs through the wing and leg muscles. Studies also suggest that neurotransmitters and neuropeptides, such as octopamine, serotonin, dopamine, acetylcholine, and neuropeptide F (NPF), also play important roles in aggressive behaviors [54].
Recent studies have shown that specific gut microbiota is associated with aggressiveness in flies. Jia et al. used sodium hypochlorite and a series of wash protocols to generate axenic flies [33]. Compared to conventional flies (Canton-S), axenic flies showed less inter-male aggressive behavior, indicating that germ-free flies have reduced inter-male aggression. Furthermore, commensal bacteria such as Acetobacter, Lactobacilli, and Enterococci promoted aggressive behaviors in axenic flies by microbial re-colonization. The authors also reported a 73% reduction in octopamine levels in germ-free flies, and genetic manipulation of the octopaminergic neuronal activity restored aggressive behavior in axenic flies. The same study also reported two key factors involved in regulating aggression via octopamine expression. One was the critical developmental period during the larval stage (48–98 h after egg laying), in which supplementation with yeast-rich diet restored aggressive behavior in axenic flies. The other factor was nutrition, as it is also important for octopamine expression, and providing proper nutrition to axenic flies normalized the aggressive behavior. These findings demonstrate that gut microbiota and nutrition during the critical developmental period affect octopamine expression, which regulates aggression in adult males [33].

2.3. Gut Microbiota and Sleep and Locomotor Activity

The Drosophila Activity Monitor (DAM) system is used to study sleep and locomotion behavior in flies [55]. In this assay, flies are housed under 12 h light/12 h dark cycle conditions [56,57]. The DAM apparatus has three major components: (1) a glass tube in which a single fly can move freely, (2) an infrared beam which is directed through the midpoint of the glass tube, and (3) a computer for recording the behavioral results [55]. In the sleep/locomotor behavior assay, the DAM system records infrared beam breaks due to flies walking in glass tubes to detect sleep or locomotion [58]. The well-known sleep behavior-related circuit in the Drosophila brain is composed of circadian neurons. Light stimulates a group of large ventral−lateral neurons (l-vLNs), which release pigment dispersing factors (PDFs) to stimulate a group of small ventral−lateral neurons (s-vLNs). Finally, the s-vLNs regulate the brain locomotor control center, the ellipsoid bodies, to inhibit sleep behavior. Both l-vLNs and s-vLNs express GABAA receptors, which might inhibit wakefulness through sleep-promoting GABAergic neurons. MB is also an important brain region that regulates sleep via the catalytic subunit of protein kinase A, an enzyme activated by the sleep-relevant cAMP pathway [59]. Locomotor activity is important for Drosophila survival, and is controlled by hormones, which can also be analyzed using the DAM system. King et al. recently reported the presence of a peptidergic circuit that links the circadian clock to locomotor activity. s-vLNs release PDFs that stimulate DN1 clock neurons which, in turn, stimulate DH44 positive pars intercerebralis (PI) neurons. DH44 positive PI neurons stimulate hugin-positive SEZ neurons, which finally release the hugin neuropeptide to the motor circuit in the ventral nerve cord that regulates locomotor activity in Drosophila [60].
The effect of the gut microbiota on sleep behavior in Drosophila remains unclear. Selkrig et al. used the isogenic Wolbachia-free D. melanogaster Canton-S strain as the wild-type flies, and performed sleep and locomotor behavior assays. The authors generated Wolbachia-free Canton-S germ-free flies by washing the eggs with NaClO, and termed the first generation as F1 and the next generation as F2. Their data revealed that neither germ-free F1 nor germ-free F2 flies exhibit any significant change in sleep behavior. Moreover, even though the germ-free F1 flies did not showed any change in the locomotor behavior, germ-free F2 flies exhibited a mild increase in the locomotor activity compared to conventional flies [35]. Another study by Silva et al. employed Canton-S and W1118 as wild-type flies, and used NaClO to wash the fly eggs for 3–5 min to generate axenic flies [61]. Their results revealed that compared to conventional flies, axenic flies tended to sleep for a longer duration and displayed reduced sleep rebound after sleep deprivation [34]. However, the gut microbiota status of the flies had a small effect on the circadian rhythmicity of the locomotor activity.
Silva et al. and Selkrig et al. focused on understanding the role of the gut microbiota in regulating Drosophila sleep and locomotion. Schretter et al. proposed a possible mechanism to explain the relationship between the gut microbiota and locomotion/sleep. In this study, Oregon-R strain was used as the wild-type, and the flies received the antibiotic-supplemented diet to generate antibiotic-treated (ABX) flies. Results showed that ABX flies have increased walking speed, enhanced daily activities, and reduced sleep during the daytime. The authors also reported that the enzyme xylose isomerase, which catalyzes the reversible isomerization of certain sugars present in Lactobacillus brevis, reduces locomotor activity by modulating sugar metabolism via stimulation of the octopaminergic neurons; however, this enzyme does not affect sleep [36].

2.4. Gut Microbiota and Temperature Related Behaviors

Environmental temperature strongly affects the physiology of ectotherms, such as Drosophila. Temperature preference behavior (flies avoid hot or cold environments) and tolerance towards hot or cold temperatures are important for survival in Drosophila. Temperature gradient assay is used to study temperature preference in flies. Different studies used distinct temperature gradient devices, but the basic principle is the same: one side of the device is at low temperature, and the other side produces high temperature. By placing an aluminum sheet between the two sides, a temperature gradient is produced. Flies are placed on the aluminum sheet and are allowed to choose their preferred temperature [62,63]. There are two different ways to study temperature avoidance behavior: one is to use the temperature gradient assay (described above), and the other is using the two-choice assay machine. The two-choice assay machine contains four quadrants that are built with a thermoelectric cooling chip and an aluminum sheet. When performing the temperature avoidance assay, the two-choice assay machine would set a constant temperature (25 °C) in one set of diagonal quadrants, and the other diagonal quadrants were set at the experimental temperature, which depends on the analysis [64]. Chill coma recovery is protocol to study temperature tolerance behavior. In this assay, flies are immersed into a water−glycol bath set at −3.5 °C (depending on the experimental design) for cold stress or exposed to 38.5 °C temperature (depending on the experimental design) for heat stress, following which the flies are allowed to recover and the recovery time is measured [37,65].
Recent studies have suggested that the gut microbiota strongly affects temperature tolerance in fruit flies. Henry et al. generated axenic flies by dechorionation, in which the fly eggs were immersed in 2.7% hypochlorite for 2 min, 70% ethanol for 2 min, and finally washed twice in autoclaved water [37]. After dechorionation, the flies were reared on autoclaved food. Their results suggest that the cold tolerance of axenic flies is defective compared to that of conventional flies. However, heat tolerance was not affected in the axenic flies. This suggests that microbiota disruption decreases the ability to cope with cold stress [37]. Studies on other Drosophila species, such as D. subobscura, suggest that conventional flies exposed to mild heat conditions (<34 °C) exhibit higher thermal tolerance than axenic flies [38].

3. Drosophila Learned Behaviors

Tremendous research progress has been made over the past 40 years on detailed mechanisms underlying Drosophila learning and memory. Several Drosophila learning and memory behaviors have been used in biological studies, including olfactory memory, visual memory, place memory, and courtship memory [66]. Ample studies have suggested that flies can learn and form memories from their experiences, and these memories can persist for hours or days. Drosophila olfactory memory and courtship memory are two popular assay systems for memory studies in the laboratory. Herein, we mainly focus on olfactory and courtship memories in Drosophila.

3.1. Olfactory Memory-Aversive and Reward Conditionings

Drosophila olfactory memory was described by Tempel et al. [4] and Tully et al. [5]. For aversive olfactory conditioning, flies receive the electric shock punishment along with exposure to a specific odor (CS+), followed by a different odor (CS−) without electric shock. For memory testing, flies are transported using a small elevator in the training machine and allowed to select between two odors (CS+ vs. CS−) in the T-maze. Both 3-octanol (OCT) and 4-methylcyclohexanol (MCH) are often used in this assay. The performance index is defined as:
( number   of   flies   in   the   CS +   odor   arm number   of   flies   in   the   CS   odor   arm ) total   number   of   flies × 100  
A performance index of a higher value indicates that flies have greater memory abilities.
The sugar-reward memory assay, described in earlier studies, is similar to the aversive olfactory memory assay, and the water-reward memory assay is a modification from the sugar-reward memory [4,67,68,69,70]. In sugar-reward and water-reward memory assays, hunger or thirsty flies are trained to pair an odor (CS+) with sugar or water, respectively. Before starting the experiment, flies are transferred to vials containing a moist filter paper for food starvation before the sugar-reward memory assay, or to vials containing dry sucrose filter paper for desiccation before the water-reward memory assay. For training, flies are moved to a training tube containing a dried filter paper and exposed to the first odor (CS−). The flies are then transferred to another training tube containing either a sucrose filter paper or a water filter paper and then exposed to the second odor (CS+). For testing, flies are allowed to choose between the two odors in a T-maze, and their distribution in the tubes was analyzed and presented as the performance index [68,71].

3.2. Courtship Memory

Already mated female flies reject male copulation attempts, which eventually leads to reduced courtship behavior of male flies. This unpleasant experience (rejection from female) also suppresses the male courtship behavior towards a virgin female [6]. The suppression of the male fly courtship behavior towards a virgin female following exposure to already mated females is defined as courtship conditioning. Before testing, naïve males are collected on the day of eclosion, and kept individually for 4–5 days. When naive males are sexually mature, they are exposed to a mated female for 1 h, and the courtship index during the first (CIinitial) and the last (CIfinal) 10 min of the 1 h experimental period was calculated. The test male is then moved to a new place and exposed to a decapitated virgin female for 10 min (CItest). In the control group, naive male flies are kept alone in a chamber for 1 h, and then transferred to a new chamber with a decapitated virgin female for 10 min (CIsham) [72]. Finally, the courtship learning index and memory index are calculated. Lower learning and memory indices indicate that male flies have better learning and memory ability. Learning index = CIfinal/CIinitial and memory index = CItest/mean CIsham [72].

3.3. Impact of the Gut Microbiota on Memory

Studies have shown that flies can be trained to associate an odor with punishment or reward [4,5,67,73]. For olfactory memory, projection neurons in the antennal lobe receive inputs from olfactory receptor neurons, and project to the lateral horn and MBs in the fly brain [74]. Notably, Drosophila MBs are critical for olfactory memory [75,76]. MB neurons are classified as αβ, α′β′, and γ neurons [77]. Blum et al. showed that in flies, learned experiences form short-term memory in the MB γ neurons, while long-term memory is formed in the MB αβ neurons [78]. In contrast, McBride et al. reported that MBs are essential for the consolidation of long-term memory during courtship conditioning [79]. Another study reported that the overlap of MB neurons is required for courtship memory and olfactory associative memory in Drosophila [80]. Growing evidence suggests that the gut microbiome may have some effects on animal behavior [81], and the interaction between the gut and the brain is critical for behaviors [82]. Several researchers have indicated a link between the gut microbiota and learning [83] or memory [84]. In particular, specific probiotics have been developed to improve learning and memory in mice [85,86]. In Drosophila, the gut microbiota is much simpler compared to other animals [87]. Fruit flies are a potential animal model to study the effects of the gut microbiota on learned behaviors; however, there is only scattered evidence. Recently, Silva et al. reported that axenic flies have reduced appetitive memory at 24 h after training, and axenic male flies exhibit decreased courtship learning and memory [34](Table 1). Further studies are needed to elucidate the impact of the gut microbiota on learned behaviors in the future.

4. Aging and Longevity

Aging is a universal biological phenomenon. Essentially, aging is a term used to describe the relationship between advancing chronological age and decline in physiological functions, such as reproductive function, muscle strength, cognitive impairment, and age-related diseases [88]. Several studies have employed animal models, such as Caenorhabditis elegans, Drosophila, and mice, to characterize the molecular and physiological changes that occur during aging [89].

Gut Microbiota and Drosophila Aging

Aging is associated with an increased risk of chronic diseases, including immune system diseases, cancer, neurodegeneration, and dysbiosis [90]. A recent study demonstrated that there are significant differences in the gut microbiota composition between healthy and unhealthy elderly adults (aged >90 years). Healthy elderly people have a higher abundance of Bacteroidetes in the gut, which provide more functional pathways for energy metabolism. However, unhealthy elderly individuals have a higher abundance of Streptococcus and other pathogenic bacteria in the gut [91]. Studies on the elderly human microbiota are not very consistent due to different internal and external parameters associated with each person; therefore, further studies using animal models are required to clarify the role of the gut microbiota in aging.
Typically, the healthy and well-maintained wild-type Drosophila, W1118, has a median lifespan of approximately 70 days, and a maximum of approximately 90 days when reared at 25 °C [92]. Aged flies exhibit serious age-related behavioral changes 21 days after eclosion, such as age-related locomotor impairment (ARLI), decreased sexual activity and reproductive behavior, reduced cold temperature sensing ability, breakdown of sleep−wake cycles, and impaired cognitive functions [63,93,94,95]. These age-related behavioral changes are associated with a change in the gene expression pattern. Aging is associated with changes in the expression of nearly 23% of genes in Drosophila, and many of these genes are related to stress response and reproduction. Perturbed expression of these genes causes impairment of several physiological processes in aged flies [96].
In adult flies, Proteobacteria (Acetobacter and Komagataeibacter) and Firmicutes (Lactobacillus and Leuconostoc) comprise a major part of the gut microbiota, especially in the stomach-like copper cell region (CCR, also see the Figure 1a), which controls the distribution and composition of the microbiota and metaplasia of the gastric epithelium via activation of the JAK/STAT signaling in the aging gut [97]. Moreover, there is a significant difference in the gut microbiota composition between young and old flies. In young flies, Acetobacter persici and L. brevis are the dominant species. However, A. malorum and L. plantarum are mainly present in the gut of old flies [98]. Studies elucidating the effects of the gut microbiota during different stages of Drosophila development are not consistent. Brummel et al. found that flies reared under axenic conditions have reduced lifespan compared to conventional flies. Furthermore, the presence of microbiota during the first week of adult life in Drosophila increases the lifespan. In contrast, the presence of microbiota during the later life decreases lifespan. The authors proposed that the gut microbiota interacts with longevity genes to modulate lifespan in Drosophila [39]. Contrary to this, Catterson et al. showed that intermittent fasting (IF, two days of feeding followed by five days of fasting) can prolong the lifespan in Drosophila. Further, the authors showed that IF for at least 30 days during adulthood enhances lifespan. The authors argued that IF increases starvation-induced resistance to oxidative and xenobiotic stress. Furthermore, IF enhances the lipid content in 60-day-old flies. Analysis of the gut 40 days post-IF revealed a significant reduction in age-related pathologies, improved gut barrier function, and reduced bacterial abundance including that of L. plantarum. IF can act independently of the TOR pathway and robustly increase the lifespan. Altogether, during the early life, short-term IF can induce long-lasting beneficial effects which could enhance longevity, at least in part, by preserving the gut health [40].

5. Alzheimer’s Diseases

Alzheimer’s disease (AD) arises due to neuronal degeneration in the brain. AD is characterized by the presence of neuritic plaques and neurofibrillary tangles, which leads to amyloid-beta (Aβ) peptide accumulation [99]. There are two major hypotheses to explain the mechanism underlying AD development. The first hypothesis is the cholinergic hypothesis. In the 1970s, studies revealed that neocortical and presynaptic cholinergic deficits are related to choline acetyltransferase (ChAT), an enzyme involved in acetylcholine (ACh) synthesis. Since ACh is the key factor involved in regulating cognitive functions, the cholinergic hypothesis proposes that β-amyloid accumulation affects cholinergic neurotransmission, and causes a reduction in choline uptake and Ach release [100,101]. The second hypothesis is the amyloid hypothesis. It has been observed that Aβ degradation is reduced with increased age or in various pathological conditions, leading to the accumulation of Aβ peptides, which finally causes neuronal death [102,103,104]. Several AD risk factors have been identified, such as aging, genetic background, amyloid precursor protein mutations, environmental factors, and heavy metal exposure [105].

5.1. Gut Microbiota and AD in Drosophila

AD patients exhibit reduced abundance of L. brevis and Bifidobacterium dentium in the gut and decreased GABA levels in the CNS [106]. Serotonin, another key neurotransmitter that regulates cognitive functions, can be synthesized by the gut microbes [15,107]. Besides neurotransmitter imbalance, neurotoxins are also implicated in AD. A recent study revealed that the neurotoxin β-N-methylamino-L-alanine (BMAA) is produced by Cyanobacteria in the gut, which contributes to AD development [106,108]. However, the impact of gut microbiota on neural circuits and related mechanisms in AD remain unclear. Overall, three Drosophila AD models have been developed that allowed scientists to uncover the relationship between AD and gut microbiota. These include elav-Gal4, UAS-BACE/UAS-APP model, GMR-Aβ42 model, and elav-Gal4; UAS-Aβ42 model (Table 1).

5.2. elav-Gal4; UAS-BACE/UAS-APP Fly Model

The UAS/Gal4 system has been used to develop AD fly models by expressing human beta-secretase (BACE) or amyloid precursor protein (APP) under the control of elav-Gal4 driver, which is expressed specifically in neurons. These flies exhibit increased amyloid deposition in neurons, loss of climbing ability, and increased neurodegeneration. A recent study further showed the association between Kefir uptake and AD in elav-Gal4; UAS-BACE/UAS-APP flies. Kefir is a probiotic that contains five major bacterial species: L. kefiranofaciens (21.96%), L. kefiri (0.2%), A. fabarum (0.17%), Lactococcus lactis (0.004%), and Rickettsiales (0.001%). The major metabolites present in Kefir are hexane (Hex), dichloromethane (DCM), ethyl acetate (EtOAc), and n-butanol (But-OH). Kefir administration to AD model flies enhanced their climbing ability, improved the survival rate, and suppressed neurodegeneration. Furthermore, although the four metabolites present if Kefir were individually able to improve the climbing activity in AD flies, only EtOAc and But-OH were able to extend the lifespan of the AD model Drosophila [41].
Westfall et al. developed a symbiotic formulation containing L. plantarum NCIMB 8826 (Lp8826), L. fermentum NCIMB 5221 (Lf5221), and Bifidobacteria longum spp. infantis NCIMB 702255 (Bi702255), along with 0.5% TFLA (polyphenol plant extract from the gastrointestinal tonic Triphala) powder. Treating elav-Gal4; UAS-BACE/UAS-APP flies with this symbiotic formulation reduced the expression of Drosophila insulin-like peptide (Dilp) including Dilp2 and Dilp3, and Dilp receptors, whereas it increased dFOXO and innate immune factor dual oxidase expression, and promoted IMD signaling. Moreover, the symbiotic formulation reduced the levels of total oxidants, suppressed lipid peroxidation (LPO), and restored the activity of the mitochondrial electron transport chain (ETC) complexes in AD model flies [42].

5.3. GMR-Aβ42 Fly Model

GMR-Aβ42 AD fly model was developed by expressing the human Aβ42 transgene under the control of the glass multimer reporter (GMR)-Gal4 driver, which is expressed in retinal cells. These flies exhibit a rough eye phenotype due to neurodegeneration, and this model is widely used to investigate mechanisms underlying AD development [109]. Liu et al. showed that L. sakei Probio 65 and L. paracasei 0291 feeding significantly reduced AD-associated neurodegeneration in GMR-Aβ42 AD model flies [43]. Moreover, Tan et al. reported that Lactobacillus rescues the rough eye phenotype in AD flies, especially the L. plantarum DR7 strain. L. plantarum DR7 can restore the gut microbiota diversity in AD model flies by increasing the abundance of Stenotrophomonas and Acetobacter, while reducing that of Wolbachia [44].

5.4. elav-Gal4; UAS-Aβ42 Fly Model

These AD model flies were developed by expressing human Aβ42 under the control of the pan-neuronal driver elav-Gal4. Similar to other AD model flies, elav-Gal4; UAS-Aβ42 flies exhibit decreased survival rates and reduced climbing abilities. Moreover, the abundance of families Acetobacteraceae and Lactobacillaceae is decreased in the gut of these flies, especially Acetobacter and Lactobacillus. Using GC-MS, it has been found that levels of acetate, which is the most abundant short-chain fatty acid (SCFA) in flies, are decreases dramatically in AD model flies [45]. In vitro and in vivo studies have demonstrated that SCFAs play a potential role in reducing Aβ levels and mitigating its toxic effects [110,111]. Furthermore, enteric dysbiosis caused due to infection with a nonpathogenic enterobacteria (Ecc15) in adult flies promotes hemocyte recruitment to the brain, leading to TNF−JNK-mediated neurodegeneration, resulting in AD development [46].

6. Parkinson’s Disease

Parkinson’s disease (PD) is a neurological disorder that affects people mainly in later years of life. In general, PD is rarely observed in those under 40 years of age, and it is estimated that about 1% of people over 60 years of age and 0.3% of the entire population develop this disease [112,113,114]. The accumulation of α-synuclein-containing Lewy bodies and loss of dopaminergic neurons in the substantia nigra are the major pathological changes observed in PD patients. The motor features commonly observed in PD patients include tremors, rigidity, and bradykinesia. Furthermore, common non-motor features observed in patients with PD are sleep dysfunction, autonomic dysfunction, and hyposmia [115]. Although the causes underlying PD development are still unknown, the major risk factors include age, environmental factors, and genetics.

6.1. Gut Microbiota and PD in Drosophila

It has been reported that in patients with PD, the abundance of Enterobacteriaceae in the gut is positively associated with the severity of postural instability [46]. Furthermore, it has been reported that, in PD patients, the gut abundance of Prevotellaceae, Blautia spp., Coprococcus spp., Roseburia, Faecalibacterium spp., and Prevotella spp. Is decreased, while that of E. coli, Ralstonia, Lactobacillus, Bifidobacteriu, Verrucomicrobiaceae, Bacteroides, Parabacteroides, Akkermansia, Butyricimonas, Veillonella, Odoribacter, Mucispirillum, and Bilophila is increased [12,116,117,118,119]. However, the effects of the gut microbiota on PD pathogenesis remain unclear. The Drosophila PD model has been used to investigate the relationship between PD and gut microbiota. Similar to the AD model, there are two model systems to study PD in Drosophila: elav-Gal4; UAS-Synuclein model, and the PINK1 mutant model (Table 1), as described below.

6.2. elav-Gal4; UAS-Synuclein Fly Model

In PD patients, there is a multiplication of or mutations (A53T, A30P, or E46K) in the α-synuclein gene. Fly PD models have been developed by expressing the mutant α-synuclein under the control of elav-Gal4 driver. Ho et al. used the A53T mutant human α-synuclein protein under the elav-Gal4 driver to develop flies with PD-like characteristics. These flies showed adult-onset loss of the dopaminergic neurons and locomotor dysfunction. Treatment with 3-hydroxybenzoic acid (3-HBA),
3,4-dihydroxybenzoic acid (3,4-diHBA), and 3-(3-hydroxyphenyl)propionic acid (3-HPPA), which are phenolic acid metabolites, inhibited α-synuclein aggregation in vitro, and improved the locomotor activity of PD model flies. It has been reported that Bacteroides ovatus could convert the flavanols catechin and epicatechin to DHCA, 3,4-diHBA, and 3-HBA. Moreover, B. ovatus, Eggerthella lenta, and Escherichia coli could produce 3-HPPA, 3,4-diHBA, and 3-HBA through metabolic processes independent of catechin and epicatechin. These findings imply that the gut microbiota might affect PD pathogenesis by modulating dietary flavanols [47].

6.3. PINK1 Mutant Fly Model

PTEN-induced kinase 1 (PINK1), a nuclear-encoded mitochondrial serine/threonine-protein kinase, has been associated with PD. In animal models with PINK1 gene mutations, PD-associated changes and symptoms are observed, such as fragmented mitochondrial cristae, enhanced oxidative stress sensitivity, locomotor defects, and dopaminergic neuronal loss [113,120]. Therefore, PINK1 with loss-of-function mutations is used to develop PD model flies. Xu et al. showed that PD flies with PINK1 mutations exhibit reduced lifespan, climbing and flight defects, degenerated flight muscles, and loss of dopaminergic neurons. It has been shown that the compound epigallocatechin-3-gallate (EGCG), a major polyphenol present in green tea, can reduce PD symptoms. Moreover, EGCG could restore the microbiota diversity in PD flies by decreasing the gut abundance of Proteobacteria and increasing the gut abundance of Firmicutes and Bacteroidetes. Moreover, in PD flies, the gut abundance of the bacterium Lactobacillus and Acetobacter is increased, but in EGCG treatment groups, it reduced the abundance of Acetobacter and L. plantarum, and rescued the locomotor defects. Furthermore, increasing the abundance of L. plantarum in EGCG treated PD flies reduced the efficacy of this polyphenol. Thus, EGCG provides neuroprotection by affecting the gut microbiota in PD flies [48].

7. Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that manifests in early childhood. It is characterized by complex behavioral phenotypes and deficits in both social and cognitive functions; however, the exact cause of ASD is still unknown [121,122]. In recent years, the association between genetic factors and ASD has been identified, including copy number variation, single nucleotide polymorphisms, and epigenetic alterations. Besides genetics, environmental factors, such as air pollutants and pesticides, also play a key role in ASD [122,123]. Recently, the Drosophila model has been used to study the relationship between ASD and chromatin remodeling, post-transcriptional regulation, protein synthesis/degradation, and cell adhesion molecules [124]. POGZ encodes the heterochromatin protein 1 α-binding protein that is critical for chromatin remodeling in humans. POGZ is believed to function as a transcriptional regulator, which is crucial for neuronal functions [125]. Downregulation of row, the Drosophila ortholog of POGZ, in neurons leads to a deficit in habituation, which is a form of non-associative learning [125]. Euchromatin histone methyltransferase (EHMT) is another example of the ASD risk gene related to chromatin remodeling [126,127,128]. Loss of EHMT in Drosophila leads to learning and memory deficits, and a significant decrease in dendritic end numbers, higher-order branching, and dendritic field complexity [129].
Recent studies suggest that the KDM5 family proteins are crucial to ASD. KDM5 family proteins are histone demethylases that regulate histone H3K4me3 modification, which is associated with promoters of transcriptionally active genes [130,131]. Loss-of-function mutations in KDM5 family proteins have been reported in patients with ASD [132,133]. Moreover, kdm5c knockout mice also exhibit abnormal learning and social behavior due to reduced spine density [134,135]. Flies carrying the mutant human kdm5c (kdm5A512P) exhibit learning and memory defects [136]. Furthermore, these flies exhibit behavioral defects, and transcriptional level changes, which are similar to a mutant allele that abolish demethylase activity. These studies suggest that KDM5 family proteins are critical for learning, memory, and social behaviors by their enzymatic function for gene activation [136].
There are several behavioral assays that can be used to study ASD in the Drosophila model. Social space assays were originally developed by Simon et al. to study ASD in adult flies [137]. This assay is carried out in a test chamber with two square glass plates (18 × 18 cm) separated by a 0.5 cm spacer, allowing the flies to be in a space. The internal space is triangular with a height and base of 15.3 cm each. Flies are placed at the bottom of the chamber, and all flies start climbing up from the same starting point at the bottom. After 20 min, the distance between the closest neighbors is measured using a camera [137]. Besides social space assays, the Drosophila activity assay is also commonly employed in the ASD model flies [138].
Chen et al. proposed that KDM5 proteins affect social behavior by regulating the gut microbiota composition [49]. In humans, the KDM5 family comprises of four members, whereas in Drosophila, only one KDM5 ortholog is present [139]. Chen et al. generated the kdm5-deficient flies and showed that loss of kdm5 leads to intestinal barrier dysfunction and changes in social behavior. In addition, KDM5 deficiency in the intestinal tissues altered the microbiota composition, leading to gut barrier defects. However, the probiotic Lactobacillus or antibiotic administration to the kdm5-deficient flies partially rescued the behavioral and cellular phenotypes, and extended the lifespan (Table 1). Furthermore, KDM5 transcriptionally regulates the immune deficiency (IMD) signaling pathway, and maintains bacterial homeostasis in a demethylase-dependent manner [134]. These studies suggest that targeting the gut microbiota might be a possible clinical therapeutic approach for treating ASD patients with abnormal IMD signaling [49].

8. Conclusions

Since Drosophila harbors a simple gut microbial community, it is easy to understand the mechanisms by which the microbiota−gut−brain axis influences the complicated animal behaviors. Moreover, several fly models of neurodegenerative diseases have been developed allowing scientists to investigate the association between gut microbes and neuronal disorders, which could pave the way towards translational studies of probiotics.
This review emphasizes the importance of recent findings on the association between the gut microbiota and neuronal functions, behavior, and neurodegenerative diseases in the Drosophila model. The gut microbiota influences temperature tolerance, sleep behavior, locomotor activity, host-outbreed strategy, and aggressive behavior, all of which are innate behaviors. Although there are some contradictions regarding the association between the gut microbiota and behavior, we speculate that these differences might be due to different host genotypes and diets used in different studies. However, studies on Drosophila sleep and locomotor behaviors provide us with clues that the gut microbiota acts as neuromodulator of the neuronal circuits [34]. The association between learned behavior and gut microbiota remains poorly understood. Silva et al. reported that gut microbiota affects appetitive long-term memory, courtship learning, and courtship long-term memory [34]. Although the role of the microbiota−gut−brain axis in aging remains unclear, we learned from fruit flies that changes in lifestyle or diet could improve lifespan [40]. Moreover, studies on the fly model suggest that drinking milk with kefir and taking symbiotic formulations or probiotic supplements reduce AD symptoms [41,42,44]. The beneficial effects of probiotic supplements and EGCG containing green tea on PD symptoms have been shown in flies [116,118]. In future studies, the first priority will be to develop novel experimental setups that facilitate aseptic conditions for tight control and precise manipulation of the gut microbiota in fruit flies [34]. We believe that the Drosophila model can help us to understand the principle underlying the microbiota−gut−brain axis and identify the potential next-generation probiotics (NGP) in the near future.

Author Contributions

Conception or design of this work: C.-H.L. and C.-L.W.; Writing the manuscript: M.-H.C., S.-M.H., H.-Y.W., Y.-C.L., C.-H.L. and C.-L.W.; Preparation of figures and tables: M.-H.C. and S.-M.H.; Suggestions and discussion: W.-H.T. and T.W.; Final approval: all authors. M.-H.C. and S.-M.H. equally contributed to this work. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the grants from Science Park, Ministry of Science and Technology (109CB01), the Ministry of Science and Technology (109-2326-B-182-001-MY3, 109-2320-B-182-025-MY3, and 109-2320-B-182-029-MY3), Chang Gung Memorial Hospital (CMRPD1K0311-2, CMRPD1K0361, and BMRPC75), and the Higher Education Sprout Project funded by the Ministry of Science and Technology and Ministry of Education.

Acknowledgments

The authors would like to thank the editor and reviewers for the editorial assistance and their valuable comments. We thank the members in C. H. Lai’s and C. L. Wu’s laboratories for their critical comments on this manuscript.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Konopka, R.J.; Benzer, S. Clock mutants of Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 1971, 68, 2112–2116. [Google Scholar] [CrossRef] [Green Version]
  2. Dow, M.A.; Schilcher, F.V. Aggression and mating success in Drosophila melanogaster. Nature 1975, 254, 511–512. [Google Scholar] [CrossRef] [PubMed]
  3. Hall, J.C. The mating of a fly. Science 1994, 264, 1702–1714. [Google Scholar] [CrossRef] [PubMed]
  4. Tempel, B.L.; Bonini, N.; Dawson, D.R.; Quinn, W.G. Reward learning in normal and mutant Drosophila. Proc. Natl. Acad. Sci. USA 1983, 80, 1482–1486. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Tully, T.; Quinn, W.G. Classical conditioning and retention in normal and mutant Drosophila melanogaster. J. Comp. Physiol. A 1985, 157, 263–277. [Google Scholar] [CrossRef]
  6. Siegel, R.W.; Hall, J.C. Conditioned responses in courtship behavior of normal and mutant Drosophila. Proc. Natl. Acad. Sci. USA 1979, 76, 3430–3434. [Google Scholar] [CrossRef] [Green Version]
  7. Feany, M.B.; Bender, W.W. A Drosophila model of Parkinson’s disease. Nature 2000, 404, 394–398. [Google Scholar] [CrossRef]
  8. Cowan, C.M.; Shepherd, D.; Mudher, A. Insights from Drosophila models of Alzheimer’s disease. Biochem. Soc. Trans. 2010, 38, 988–992. [Google Scholar] [CrossRef]
  9. Tue, N.T.; Dat, T.Q.; Ly, L.L.; Anh, V.D.; Yoshida, H. Insights from Drosophila melanogaster model of Alzheimer’s disease. Front. Biosci. 2020, 25, 134–146. [Google Scholar] [CrossRef]
  10. O’Hara, A.M.; Shanahan, F. The gut flora as a forgotten organ. EMBO Rep. 2006, 7, 688–693. [Google Scholar] [CrossRef] [Green Version]
  11. Fung, T.C.; Olson, C.A.; Hsiao, E.Y. Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 2017, 20, 145–155. [Google Scholar] [CrossRef] [PubMed]
  12. Lin, C.H.; Chen, C.C.; Chiang, H.L.; Liou, J.M.; Chang, C.M.; Lu, T.P.; Chuang, E.Y.; Tai, Y.C.; Cheng, C.; Lin, H.Y.; et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease. J. Neuroinflamm. 2019, 16, 129. [Google Scholar] [CrossRef] [PubMed]
  13. De Palma, G.; Lynch, M.D.; Lu, J.; Dang, V.T.; Deng, Y.; Jury, J.; Umeh, G.; Miranda, P.M.; Pigrau Pastor, M.; Sidani, S.; et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci. Transl. Med. 2017, 9, eaaf6397. [Google Scholar] [CrossRef] [PubMed]
  14. Hsiao, E.Y.; McBride, S.W.; Hsien, S.; Sharon, G.; Hyde, E.R.; McCue, T.; Codelli, J.A.; Chow, J.; Reisman, S.E.; Petrosino, J.F.; et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013, 155, 1451–1463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Strandwitz, P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018, 1693, 128–133. [Google Scholar] [CrossRef] [PubMed]
  16. Logsdon, A.F.; Erickson, M.A.; Rhea, E.M.; Salameh, T.S.; Banks, W.A. Gut reactions: How the blood-brain barrier connects the microbiome and the brain. Exp. Biol. Med. 2018, 243, 159–165. [Google Scholar] [CrossRef]
  17. Kaelberer, M.M.; Buchanan, K.L.; Klein, M.E.; Barth, B.B.; Montoya, M.M.; Shen, X.; Bohorquez, D.V. A gut-brain neural circuit for nutrient sensory transduction. Science 2018, 361, eaat5236. [Google Scholar] [CrossRef] [Green Version]
  18. Sampson, T.R.; Debelius, J.W.; Thron, T.; Janssen, S.; Shastri, G.G.; Ilhan, Z.E.; Challis, C.; Schretter, C.E.; Rocha, S.; Gradinaru, V.; et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease. Cell 2016, 167, 1469–1480. [Google Scholar] [CrossRef] [Green Version]
  19. Harach, T.; Jammes, F.; Muller, C.; Duthilleul, N.; Cheatham, V.; Zufferey, V.; Cheatham, D.; Lukasheva, Y.A.; Lasser, T.; Bolmont, T. Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer’s disease. Neurobiol. Aging 2017, 51, 83–96. [Google Scholar] [CrossRef]
  20. Mayer, E.A.; Tillisch, K.; Gupta, A. Gut/brain axis and the microbiota. J. Clin. Investig. 2015, 125, 926–938. [Google Scholar] [CrossRef]
  21. Kitani-Morii, F.; Friedland, R.P.; Yoshida, H.; Mizuno, T. Drosophila as a Model for Microbiota Studies of Neurodegeneration. J. Alzheimers Dis. 2021, 84, 479–490. [Google Scholar] [CrossRef] [PubMed]
  22. Salim, S.; Banu, A.; Alwa, A.; Gowda, S.B.M.; Mohammad, F. The gut-microbiota-brain axis in autism: What Drosophila models can offer? J. Neurodev. Disord. 2021, 13, 37. [Google Scholar] [CrossRef]
  23. Kim, S.M.; Su, C.Y.; Wang, J.W. Neuromodulation of Innate Behaviors in Drosophila. Annu. Rev. Neurosci. 2017, 40, 327–348. [Google Scholar] [CrossRef]
  24. Strauss, R.; Hanesch, U.; Kinkelin, M.; Wolf, R.; Heisenberg, M. No-bridge of Drosophila melanogaster: Portrait of a structural brain mutant of the central complex. J. Neurogenet. 1992, 8, 125–155. [Google Scholar] [CrossRef] [PubMed]
  25. Chen, S.; Lee, A.Y.; Bowens, N.M.; Huber, R.; Kravitz, E.A. Fighting fruit flies: A model system for the study of aggression. Proc. Natl. Acad. Sci. USA 2002, 99, 5664–5668. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Levine, J.D.; Funes, P.; Dowse, H.B.; Hall, J.C. Resetting the circadian clock by social experience in Drosophila melanogaster. Science 2002, 298, 2010–2012. [Google Scholar] [CrossRef]
  27. Hendricks, J.C.; Finn, S.M.; Panckeri, K.A.; Chavkin, J.; Williams, J.A.; Sehgal, A.; Pack, A.I. Rest in Drosophila is a sleep-like state. Neuron 2000, 25, 129–138. [Google Scholar] [CrossRef] [Green Version]
  28. Waddington, C.H.; Woolf, B.; Perry, M.M. Environment Selection by Drosophila Mutants. Evolution 1954, 8, 89–96. [Google Scholar] [CrossRef] [Green Version]
  29. Ugur, B.; Chen, K.; Bellen, H.J. Drosophila tools and assays for the study of human diseases. Dis. Model. Mech. 2016, 9, 235–244. [Google Scholar] [CrossRef] [Green Version]
  30. Kume, K.; Kume, S.; Park, S.K.; Hirsh, J.; Jackson, F.R. Dopamine is a regulator of arousal in the fruit fly. J. Neurosci. 2005, 25, 7377–7384. [Google Scholar] [CrossRef] [Green Version]
  31. Heys, C.; Lize, A.; Colinet, H.; Price, T.A.R.; Prescott, M.; Ingleby, F.; Lewis, Z. Evidence That the Microbiota Counteracts Male Outbreeding Strategy by Inhibiting Sexual Signaling in Females. Front. Ecol. Evol. 2018, 6, 29. [Google Scholar] [CrossRef] [Green Version]
  32. Delbare, S.Y.N.; Ahmed-Braimah, Y.H.; Wolfner, M.F.; Clark, A.G. Interactions between the microbiome and mating influence the female’s transcriptional profile in Drosophila melanogaster. Sci. Rep. 2020, 10, 18168. [Google Scholar] [CrossRef] [PubMed]
  33. Jia, Y.C.; Jin, S.; Hu, K.K.; Geng, L.; Han, C.H.; Kang, R.X.; Pang, Y.X.; Ling, E.J.; Tan, E.K.; Pan, Y.F.; et al. Gut microbiome modulates Drosophila aggression through octopamine signaling. Nat. Commun. 2021, 12, 2698. [Google Scholar] [CrossRef]
  34. Silva, V.; Palacios-Munoz, A.; Okray, Z.; Adair, K.L.; Waddell, S.; Douglas, A.E.; Ewer, J. The impact of the gut microbiome on memory and sleep in Drosophila. J. Exp. Biol. 2021, 224, jeb233619. [Google Scholar] [CrossRef]
  35. Selkrig, J.; Mohammad, F.; Ng, S.H.; Chua, J.Y.; Tumkaya, T.; Ho, J.; Chiang, Y.N.; Rieger, D.; Pettersson, S.; Helfrich-Forster, C.; et al. The Drosophila microbiome has a limited influence on sleep, activity, and courtship behaviors. Sci. Rep. 2018, 8, 10646. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Schretter, C.E.; Vielmetter, J.; Bartos, I.; Marka, Z.; Marka, S.; Argade, S.; Mazmanian, S.K. A gut microbial factor modulates locomotor behaviour in Drosophila. Nature 2018, 563, 402. [Google Scholar] [CrossRef] [PubMed]
  37. Henry, Y.; Colinet, H. Microbiota disruption leads to reduced cold tolerance in Drosophila flies. Sci. Nat. 2018, 105, 59. [Google Scholar] [CrossRef] [PubMed]
  38. Jaramillo, A.; Castaneda, L.E. Gut Microbiota of Drosophila subobscura Contributes to Its Heat Tolerance and Is Sensitive to Transient Thermal Stress. Front. Microbiol. 2021, 12, 886. [Google Scholar] [CrossRef]
  39. Brummel, T.; Ching, A.; Seroude, L.; Simon, A.F.; Benzer, S. Drosophila lifespan enhancement by exogenous bacteria. Proc. Natl. Acad. Sci. USA 2004, 101, 12974–12979. [Google Scholar] [CrossRef] [Green Version]
  40. Catterson, J.H.; Khericha, M.; Dyson, M.C.; Vincent, A.J.; Callard, R.; Haveron, S.M.; Rajasingam, A.; Ahmad, M.; Partridge, L. Short-Term, Intermittent Fasting Induces Long-Lasting Gut Health and TOR-Independent Lifespan Extension. Curr. Biol. 2018, 28, 1714. [Google Scholar] [CrossRef] [Green Version]
  41. Batista, L.L.; Malta, S.M.; Silva, H.C.G.; Borges, L.D.F.; Rocha, L.O.; da Silva, J.R.; Rodrigues, T.S.; Venturini, G.; Padilha, K.; Pereira, A.D.; et al. Kefir metabolites in a fly model for Alzheimer’s disease. Sci. Rep. 2021, 11, 11262. [Google Scholar] [CrossRef] [PubMed]
  42. Westfall, S.; Lomis, N.; Prakash, S. A novel synbiotic delays Alzheimer’s disease onset via combinatorial gut-brain-axis signaling in Drosophila melanogaster. PLoS ONE 2019, 14, e0214985. [Google Scholar]
  43. Liu, G.; Tan, F.H.; Lau, S.A.; Jaafar, M.H.; Chung, F.Y.; Azzam, G.; Liong, M.T.; Li, Y. Lactic acid bacteria feeding reversed the malformed eye structures and ameliorated gut microbiota profiles of Drosophila melanogaster Alzheimer’s Disease model. J. Appl. Microbiol. 2020. [Google Scholar] [CrossRef] [PubMed]
  44. Tan, F.H.P.; Liu, G.; Lau, S.A.; Jaafar, M.H.; Park, Y.H.; Azzam, G.; Li, Y.; Liong, M.T. Lactobacillus probiotics improved the gut microbiota profile of a Drosophila melanogaster Alzheimer’s disease model and alleviated neurodegeneration in the eye. Benef. Microbes 2020, 11, 79–89. [Google Scholar] [CrossRef] [PubMed]
  45. Kong, Y.; Jiang, B.; Luo, X. Gut microbiota influences Alzheimer’s disease pathogenesis by regulating acetate in Drosophila model. Future Microbiol. 2018, 13, 1117–1128. [Google Scholar] [CrossRef]
  46. Wu, S.C.; Cao, Z.S.; Chang, K.M.; Juang, J.L. Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in Drosophila. Nat. Commun. 2017, 8, 24. [Google Scholar] [CrossRef]
  47. Ho, L.; Zhao, D.; Ono, K.; Ruan, K.; Mogno, I.; Tsuji, M.; Carry, E.; Brathwaite, J.; Sims, S.; Frolinger, T.; et al. Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity. J. Nutr. Biochem. 2019, 64, 170–181. [Google Scholar] [CrossRef]
  48. Xu, Y.; Xie, M.M.; Xue, J.S.; Xiang, L.; Li, Y.L.; Xiao, J.; Xiao, G.R.; Wang, H.L. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson’s disease. FASEB J. 2020, 34, 5931–5950. [Google Scholar] [CrossRef] [Green Version]
  49. Chen, K.; Luan, X.T.; Liu, Q.S.; Wang, J.W.; Chang, X.X.; Snijders, A.M.; Mao, J.H.; Secombe, J.; Dan, Z.; Chen, J.H.; et al. Drosophila Histone Demethylase KDM5 Regulates Social Behavior through Immune Control and Gut Microbiota Maintenance. Cell Host Microb. 2019, 25, 537. [Google Scholar] [CrossRef] [Green Version]
  50. Yamamoto, D.; Koganezawa, M. Genes and circuits of courtship behaviour in Drosophila males. Nat. Rev. Neurosci. 2013, 14, 681–692. [Google Scholar] [CrossRef]
  51. Leftwich, P.T.; Clarke, N.V.E.; Hutchings, M.I.; Chapman, T. Gut microbiomes and reproductive isolation in Drosophila. Proc. Natl. Acad. Sci. USA 2017, 114, 12767–12772. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. van Houte, S.; Ekroth, A.K.E.; Broniewski, J.M.; Chabas, H.; Ashby, B.; Bondy-Denomy, J.; Gandon, S.; Boots, M.; Paterson, S.; Buckling, A.; et al. The diversity-generating benefits of a prokaryotic adaptive immune system. Nature 2016, 532, 385. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Newell, N.R.; Ray, S.; Dalton, J.E.; Fortier, J.C.; Kao, J.C.Y.; Chang, P.T.L.; Nuzhdin, S.V.; Arbeitman, M.N. The Drosophila Post-mating Response: Gene Expression and Behavioral Changes Reveal Perdurance and Variation in Cross-Tissue Interactions. G3-Genes Genom. Genet. 2020, 10, 967–983. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Zwarts, L.; Versteven, M.; Callaerts, P. Genetics and neurobiology of aggression in Drosophila. Fly 2012, 6, 35–48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Pfeiffenberger, C.; Lear, B.C.; Keegan, K.P.; Allada, R. Locomotor activity level monitoring using the Drosophila Activity Monitoring (DAM) System. Cold Spring Harb Protoc. 2010, 2010, pdb-prot5518. [Google Scholar] [CrossRef] [PubMed]
  56. Shaw, P.J.; Tononi, G.; Greenspan, R.J.; Robinson, D.F. Stress response genes protect against lethal effects of sleep deprivation in Drosophila. Nature 2002, 417, 287–291. [Google Scholar] [CrossRef]
  57. Donlea, J.M.; Pimentel, D.; Miesenbock, G. Neuronal Machinery of Sleep Homeostasis in Drosophila. Neuron 2014, 81, 860–872. [Google Scholar] [CrossRef] [Green Version]
  58. Cichewicz, K.; Hirsh, J. ShinyR-DAM: A program analyzing Drosophila activity, sleep and circadian rhythms. Commun. Biol. 2018, 1, 25. [Google Scholar] [CrossRef]
  59. Harbison, S.T.; Mackay, T.F.C.; Anholt, R.R.H. Understanding the neurogenetics of sleep: Progress from Drosophila. Trends Genet. 2009, 25, 262–269. [Google Scholar] [CrossRef] [Green Version]
  60. King, A.N.; Barber, A.F.; Smith, A.E.; Dreyer, A.P.; Sitaraman, D.; Nitabach, M.N.; Cavanaugh, D.J.; Sehgal, A. A Peptidergic Circuit Links the Circadian Clock to Locomotor Activity. Curr. Biol. 2017, 27, 1915–1927. [Google Scholar] [CrossRef] [Green Version]
  61. Koyle, M.L.; Veloz, M.; Judd, A.M.; Wong, A.C.N.; Newell, P.D.; Douglas, A.E.; Chaston, J.M. Rearing the Fruit Fly Drosophila melanogaster Under Axenic and Gnotobiotic Conditions. J. Vis. Exp. 2016, 113, e54219. [Google Scholar] [CrossRef] [PubMed]
  62. Goda, T.; Leslie, J.R.; Hamada, F.N. Design and Analysis of Temperature Preference Behavior and its Circadian Rhythm in Drosophila. J. Vis. Exp. 2014, 83, e51097. [Google Scholar] [CrossRef] [PubMed]
  63. Shih, H.W.; Wu, C.L.; Chang, S.W.; Liu, T.H.; Lai, J.S.Y.; Fu, T.F.; Fu, C.C.; Chiang, A.S. Parallel circuits control temperature preference in Drosophila during ageing. Nat. Commun. 2015, 6, 7775. [Google Scholar] [CrossRef] [Green Version]
  64. Gallio, M.; Ofstad, T.A.; Macpherson, L.J.; Wang, J.W.; Zuker, C.S. The coding of temperature in the Drosophila brain. Cell 2011, 144, 614–624. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Macdonald, S.S.; Rako, L.; Batterham, P.; Hoffmann, A.A. Dissecting chill coma recovery as a measure of cold resistance: Evidence for a biphasic response in Drosophila melanogaster. J. Insect Physiol. 2004, 50, 695–700. [Google Scholar] [CrossRef] [PubMed]
  66. Kahsai, L.; Zars, T. Learning and Memory in Drosophila: Behavior, Genetics, and Neural Systems. Int. Rev. Neurobiol. 2011, 99, 139–167. [Google Scholar] [PubMed]
  67. Schwaerzel, M.; Monastirioti, M.; Scholz, H.; Friggi-Grelin, F.; Birman, S.; Heisenberg, M. Dopamine and octopamine differentiate between aversive and appetitive olfactory memories in Drosophila. J. Neurosci. 2003, 23, 10495–10502. [Google Scholar] [CrossRef] [Green Version]
  68. Lin, S.; Owald, D.; Chandra, V.; Talbot, C.; Huetteroth, W.; Waddell, S. Neural correlates of water reward in thirsty Drosophila. Nat. Neurosci 2014, 17, 1536–1542. [Google Scholar] [CrossRef] [Green Version]
  69. Shyu, W.H.; Chiu, T.H.; Chiang, M.H.; Cheng, Y.C.; Tsai, Y.L.; Fu, T.F.; Wu, T.; Wu, C.L. Neural circuits for long-term water-reward memory processing in thirsty Drosophila. Nat. Commun. 2017, 8, 15230. [Google Scholar] [CrossRef] [Green Version]
  70. Lee, W.P.; Chiang, M.H.; Chang, L.Y.; Lee, J.Y.; Tsai, Y.L.; Chiu, T.H.; Chiang, H.C.; Fu, T.F.; Wu, T.; Wu, C.L. Mushroom body subsets encode CREB2-dependent water-reward long-term memory in Drosophila. PLoS Genet. 2020, 16, e1008963. [Google Scholar] [CrossRef]
  71. Krashes, M.J.; Waddell, S. Rapid consolidation to a radish and protein synthesis-dependent long-term memory after single-session appetitive olfactory conditioning in Drosophila. J. Neurosci. 2008, 28, 3103–3113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Ejima, A.; Griffith, L.C. Assay for courtship suppression in Drosophila. Cold Spring Harb Protoc. 2011, 2011, pdb.prot5575. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Quinn, W.G.; Harris, W.A.; Benzer, S. Conditioned Behavior in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 1974, 71, 708. [Google Scholar] [CrossRef] [Green Version]
  74. Turner, G.C.; Bazhenov, M.; Laurent, G. Olfactory representations by Drosophila mushroom body neurons. J. Neurophysiol. 2008, 99, 734–746. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Roman, G.; Davis, R.L. Molecular biology and anatomy of Drosophila olfactory associative learning. Bioessays 2001, 23, 571–581. [Google Scholar] [CrossRef]
  76. Davis, R.L. Olfactory memory formation in Drosophila: From molecular to systems neuroscience. Annu. Rev. Neurosci. 2005, 28, 275–302. [Google Scholar] [CrossRef] [Green Version]
  77. Lee, T.; Lee, A.; Luo, L. Development of the Drosophila mushroom bodies: Sequential generation of three distinct types of neurons from a neuroblast. Development 1999, 126, 4065–4076. [Google Scholar] [CrossRef]
  78. Blum, A.L.; Li, W.; Cressy, M.; Dubnau, J. Short- and long-term memory in Drosophila require cAMP signaling in distinct neuron types. Curr. Biol. 2009, 19, 1341–1350. [Google Scholar] [CrossRef] [Green Version]
  79. McBride, S.M.; Giuliani, G.; Choi, C.; Krause, P.; Correale, D.; Watson, K.; Baker, G.; Siwicki, K.K. Mushroom body ablation impairs short-term memory and long-term memory of courtship conditioning in Drosophila melanogaster. Neuron 1999, 24, 967–977. [Google Scholar] [CrossRef] [Green Version]
  80. Montague, S.A.; Baker, B.S. Memory Elicited by Courtship Conditioning Requires Mushroom Body Neuronal Subsets Similar to Those Utilized in Appetitive Memory. PLoS ONE 2016, 11, e0164516. [Google Scholar] [CrossRef]
  81. Vuong, H.E.; Yano, J.M.; Fung, T.C.; Hsiao, E.Y. The Microbiome and Host Behavior. Annu. Rev. Neurosci. 2017, 40, 21–49. [Google Scholar] [CrossRef] [PubMed]
  82. Morais, L.H.; Schreiber, H.L.T.; Mazmanian, S.K. The gut microbiota-brain axis in behaviour and brain disorders. Nat. Rev. Microbiol. 2021, 19, 241–255. [Google Scholar] [CrossRef] [PubMed]
  83. Carlson, A.L.; Xia, K.; Azcarate-Peril, M.A.; Goldman, B.D.; Ahn, M.; Styner, M.A.; Thompson, A.L.; Geng, X.; Gilmore, J.H.; Knickmeyer, R.C. Infant Gut Microbiome Associated With Cognitive Development. Biol. Psychiatry 2018, 83, 148–159. [Google Scholar] [CrossRef] [PubMed]
  84. Li, W.; Dowd, S.E.; Scurlock, B.; Acosta-Martinez, V.; Lyte, M. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol. Behav. 2009, 96, 557–567. [Google Scholar] [CrossRef] [PubMed]
  85. Matthews, D.M.; Jenks, S.M. Ingestion of Mycobacterium vaccae decreases anxiety-related behavior and improves learning in mice. Behav. Processes 2013, 96, 27–35. [Google Scholar] [CrossRef]
  86. Smith, C.J.; Emge, J.R.; Berzins, K.; Lung, L.; Khamishon, R.; Shah, P.; Rodrigues, D.M.; Sousa, A.J.; Reardon, C.; Sherman, P.M.; et al. Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 307, G793–G802. [Google Scholar] [CrossRef]
  87. Wong, C.N.; Ng, P.; Douglas, A.E. Low-diversity bacterial community in the gut of the fruitfly Drosophila melanogaster. Environ. Microbiol. 2011, 13, 1889–1900. [Google Scholar] [CrossRef] [Green Version]
  88. Melzer, D.; Pilling, L.C.; Ferrucci, L. The genetics of human ageing. Nat. Rev. Genet. 2020, 21, 88–101. [Google Scholar] [CrossRef]
  89. Kim, S.; Jazwinski, S.M. The Gut Microbiota and Healthy Aging: A Mini-Review. Gerontology 2018, 64, 513–520. [Google Scholar] [CrossRef]
  90. Ragonnaud, E.; Biragyn, A. Gut microbiota as the key controllers of “healthy” aging of elderly people. Immun. Ageing 2021, 18, 2. [Google Scholar] [CrossRef]
  91. Zhang, S.Y.; Zeng, B.; Chen, Y.F.; Yang, M.Y.; Kong, F.L.; Wei, L.M.; Li, F.; Zhao, J.C.; Li, Y. Gut microbiota in healthy and unhealthy long-living people. Gene 2021, 779, 145510. [Google Scholar] [CrossRef] [PubMed]
  92. Ziehm, M.; Piper, M.D.; Thornton, J.M. Analysing variation in Drosophila aging across independent experimental studies: A meta-analysis of survival data. Aging Cell 2013, 12, 917–922. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Iliadi, K.G.; Boulianne, G.L. Age-related behavioral changes in Drosophila. Ann. N. Y. Acad. Sci. 2010, 1197, 9–18. [Google Scholar] [CrossRef] [PubMed]
  94. Jones, M.A.; Grotewiel, M. Drosophila as a model for age-related impairment in locomotor and other behaviors. Exp. Gerontol. 2011, 46, 320–325. [Google Scholar] [CrossRef] [Green Version]
  95. Koh, K.; Evans, J.M.; Hendricks, J.C.; Sehgal, A. A Drosophila model for age-associated changes in sleep: Wake cycles. Proc. Natl. Acad. Sci. USA 2006, 103, 13843–13847. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Pletcher, S.D.; Macdonald, S.J.; Marguerie, R.; Certa, U.; Stearns, S.C.; Goldstein, D.B.; Partridge, L. Genome-wide transcript profiles in aging and calorically restricted Drosophila melanogaster. Curr. Biol. 2002, 12, 712–723. [Google Scholar] [CrossRef] [Green Version]
  97. Li, H.; Qi, Y.; Jasper, H. Preventing Age-Related Decline of Gut Compartmentalization Limits Microbiota Dysbiosis and Extends Lifespan. Cell Host Microbe 2016, 19, 240–253. [Google Scholar] [CrossRef] [Green Version]
  98. Lee, H.-Y.; Lee, S.-H.; Lee, J.-H.; Lee, W.-J.; Min, K.-J. The role of commensal microbes in the lifespan of Drosophila melanogaster. Aging 2019, 11, 4611–4640. [Google Scholar] [CrossRef]
  99. De-Paula, V.J.; Radanovic, M.; Diniz, B.S.; Forlenza, O.V. Alzheimer’s Disease. In Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease; Harris, J.R., Ed.; Springer: Dordrecht, The Netherlands, 2012; pp. 329–352. [Google Scholar]
  100. Francis, P.T.; Palmer, A.M.; Snape, M.; Wilcock, G.K. The cholinergic hypothesis of Alzheimer’s disease: A review of progress. J. Neurol. Neurosurg. Psychiatry 1999, 66, 137–147. [Google Scholar] [CrossRef]
  101. Ferreira-Vieira, T.H.; Guimaraes, I.M.; Silva, F.R.; Ribeiro, F.M. Alzheimer’s disease: Targeting the Cholinergic System. Curr. Neuropharmacol. 2016, 14, 101–115. [Google Scholar] [CrossRef] [Green Version]
  102. Ricciarelli, R.; Fedele, E. The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind. Curr. Neuropharmacol. 2017, 15, 926–935. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Kametani, F.; Hasegawa, M. Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer’s Disease. Front. Neurosci. 2018, 12, 25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Paroni, G.; Bisceglia, P.; Seripa, D. Understanding the Amyloid Hypothesis in Alzheimer’s Disease. J. Alzheimers Dis. 2019, 68, 493–510. [Google Scholar] [CrossRef] [PubMed]
  105. Breijyeh, Z.; Karaman, R. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules 2020, 25, 5789. [Google Scholar] [CrossRef]
  106. Szablewski, L. Human Gut Microbiota in Health and Alzheimer’s Disease. J. Alzheimers Dis. 2018, 62, 549–560. [Google Scholar] [CrossRef]
  107. Stasi, C.; Sadalla, S.; Milani, S. The Relationship Between the Serotonin Metabolism, Gut-microbiota and the Gut-brain Axis. Curr. Drug Metab. 2019, 20, 646–655. [Google Scholar] [CrossRef] [Green Version]
  108. Lakhan, S.; Caro, M.; Hadzimichalis, N. NMDA Receptor Activity in Neuropsychiatric Disorders. Front. Psychiatry 2013, 4, 52. [Google Scholar] [CrossRef] [Green Version]
  109. Cao, W.; Song, H.J.; Gangi, T.; Kelkar, A.; Antani, I.; Garza, D.; Konsolaki, M. Identification of novel genes that modify phenotypes induced by Alzheimer’s beta-amyloid overexpression in Drosophila. Genetics 2008, 178, 1457–1471. [Google Scholar] [CrossRef] [Green Version]
  110. Ann Dipika Binosha Fernando, W.M.; Rainey-Smith, S.R.; Martins, I.J.; Martins, R.N. In vitro study to assess the potential of short chain fatty acids (scfa) as therapeutic agents for alzheimer’s disease. Alzheimer’s Dement. 2014, 10, P626-P626. [Google Scholar] [CrossRef]
  111. Lei, E.; Vacy, K.; Boon, W.C. Fatty acids and their therapeutic potential in neurological disorders. Neurochem. Int. 2016, 95, 75–84. [Google Scholar] [CrossRef]
  112. Tysnes, O.B.; Storstein, A. Epidemiology of Parkinson’s disease. J. Neural. Transm. 2017, 124, 901–905. [Google Scholar] [CrossRef]
  113. Kong, Y.; Wang, L.Y.; Jiang, B.C. The Role of Gut Microbiota in Aging and Aging Related Neurodegenerative Disorders: Insights from Drosophila Model. Life 2021, 11, 855. [Google Scholar] [CrossRef] [PubMed]
  114. Iijima, M.; Morimoto, R.; Kitagawa, K. Investigation of the consultation status and clinical symptoms of patients with Parkinson’s disease after the spread of COVID-19. Mov. Disord. 2021, 36, S278-S278. [Google Scholar]
  115. Kalia, L.V.; Lang, A.E. Parkinson’s disease. Lancet 2015, 386, 896–912. [Google Scholar] [CrossRef]
  116. Wang, Y. Gut microbiota are related to Parkinson’s disease. J. Neurol. Sci. 2017, 381, 1047. [Google Scholar] [CrossRef]
  117. Keshavarzian, A.; Green, S.J.; Engen, P.A.; Voigt, R.M.; Naqib, A.; Forsyth, C.B.; Mutlu, E.; Shannon, K.M. Colonic bacterial composition in Parkinson’s disease. Mov. Disord. 2015, 30, 1351–1360. [Google Scholar] [CrossRef]
  118. Gerhardt, S.; Mohajeri, M.H. Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative Diseases. Nutrients 2018, 10, 708. [Google Scholar] [CrossRef] [Green Version]
  119. Forsyth, C.B.; Shannon, K.M.; Kordower, J.H.; Voigt, R.M.; Shaikh, M.; Jaglin, J.A.; Estes, J.D.; Dodiya, H.B.; Keshavarzian, A. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson’s disease. PLoS ONE 2011, 6, e28032. [Google Scholar] [CrossRef] [Green Version]
  120. Pickrell, A.M.; Youle, R.J. The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease. Neuron 2015, 85, 257–273. [Google Scholar] [CrossRef] [Green Version]
  121. Carr, J.E.; LeBlanc, L.A. Autism spectrum disorders in early childhood: An overview for practicing physicians. Prim. Care 2007, 34, 343–359, abstract viii. [Google Scholar] [CrossRef]
  122. Fakhoury, M. Autistic spectrum disorders: A review of clinical features, theories and diagnosis. Int. J. Dev. Neurosci. 2015, 43, 70–77. [Google Scholar] [CrossRef] [PubMed]
  123. Karimi, P.; Kamali, E.; Mousavi, S.M.; Karahmadi, M. Environmental factors influencing the risk of autism. J. Res. Med. Sci. 2017, 22, 27. [Google Scholar] [PubMed]
  124. Tian, Y.; Zhang, Z.C.; Han, J.H. Drosophila Studies on Autism Spectrum Disorders. Neurosci. Bull. 2017, 33, 737–746. [Google Scholar] [CrossRef] [PubMed]
  125. Stessman, H.A.F.; Willemsen, M.H.; Fenckova, M.; Penn, O.; Hoischen, A.; Xiong, B.; Wang, T.Y.; Hoekzema, K.; Vives, L.; Voge, I.; et al. Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders. Am. J. Hum. Genet. 2016, 98, 541–552. [Google Scholar] [CrossRef] [Green Version]
  126. Ogawa, H.; Ishiguro, K.; Gaubatz, S.; Livingston, D.M.; Nakatani, Y. A complex with chromatin modifiers that occupies E2F-and Myc-responsive genes in G(0) cells. Science 2002, 296, 1132–1136. [Google Scholar] [CrossRef]
  127. Tachibana, M.; Sugimoto, K.; Nozaki, M.; Ueda, J.; Ohta, T.; Ohki, M.; Fukuda, M.; Takeda, N.; Niida, H.; Kato, H.; et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev. 2002, 16, 1779–1791. [Google Scholar] [CrossRef] [Green Version]
  128. Mis, J.; Ner, S.S.; Grigliatti, T.A. Identification of three histone methyltransferases in Drosophila: dG9a is a suppressor of PEV and is required for gene silencing. Mol. Genet. Genomics. 2006, 275, 513–526. [Google Scholar] [CrossRef]
  129. Kramer, J.M.; Kochinke, K.; Oortveld, M.A.W.; Marks, H.; Kramer, D.; de Jong, E.K.; Asztalos, Z.; Westwood, J.T.; Stunnenberg, H.G.; Sokolowski, M.B.; et al. Epigenetic Regulation of Learning and Memory by Drosophila EHMT/G9a. PLoS Biol. 2011, 9, e1000569. [Google Scholar] [CrossRef] [Green Version]
  130. Rasmussen, P.B.; Staller, P. The KDM5 family of histone demethylases as targets in oncology drug discovery. Epigenomics 2014, 6, 277–286. [Google Scholar] [CrossRef]
  131. Liu, X.; Secombe, J. The Histone Demethylase KDM5 Activates Gene Expression by Recognizing Chromatin Context through Its PHD Reader Motif. Cell Rep. 2015, 13, 2219–2231. [Google Scholar] [CrossRef] [Green Version]
  132. Fieremans, N.; Van Esch, H.; de Ravel, T.; Van Driessche, J.; Belet, S.; Bauters, M.; Froyen, G. Microdeletion of the escape genes KDM5C and IQSEC2 in a girl with severe intellectual disability and autistic features. Eur. J. Med. Genet. 2015, 58, 324–327. [Google Scholar] [CrossRef] [PubMed]
  133. Martin, H.C.; Jones, W.D.; McIntyre, R.; Sanchez-Andrade, G.; Sanderson, M.; Stephenson, J.D.; Jones, C.P.; Handsaker, J.; Gallone, G.; Bruntraeger, M.; et al. Quantifying the contribution of recessive coding variation to developmental disorders. Science 2018, 362, 1161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  134. Iwase, S.; Brookes, E.; Agarwal, S.; Badeaux, A.I.; Ito, H.; Vallianatos, C.N.; Tomassy, G.S.; Kasza, T.; Lin, G.; Thompson, A.; et al. A Mouse Model of X-linked Intellectual Disability Associated with Impaired Removal of Histone Methylation. Cell Rep. 2016, 14, 1000–1009. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  135. Scandaglia, M.; Lopez-Atalaya, J.P.; Medrano-Fernandez, A.; Lopez-Cascales, M.T.; del Blanco, B.; Lipinski, M.; Benito, E.; Olivares, R.; Iwase, S.; Shi, Y.; et al. Loss of Kdm5c Causes Spurious Transcription and Prevents the Fine-Tuning of Activity-Regulated Enhancers in Neurons. Cell Rep. 2017, 21, 47–59. [Google Scholar] [CrossRef] [Green Version]
  136. Zamurrad, S.; Hatch, H.A.M.; Drelon, C.; Belalcazar, H.M.; Secombe, J. A Drosophila Model of Intellectual Disability Caused by Mutations in the Histone Demethylase KDM5. Cell Rep. 2018, 22, 2359–2369. [Google Scholar] [CrossRef] [Green Version]
  137. Simon, A.F.; Chou, M.T.; Salazar, E.D.; Nicholson, T.; Saini, N.; Metchev, S.; Krantz, D.E. A simple assay to study social behavior in Drosophila: Measurement of social space within a group. Genes Brain Behav. 2012, 11, 243–252. [Google Scholar] [CrossRef] [Green Version]
  138. Ueoka, I.; Kawashima, H.; Konishi, A.; Aoki, M.; Tanaka, R.; Yoshida, H.; Maeda, T.; Ozaki, M.; Yamaguchi, M. Novel Drosophila model for psychiatric disorders including autism spectrum disorder by targeting of ATP-binding cassette protein A. Exp. Neurol. 2018, 300, 51–59. [Google Scholar] [CrossRef]
  139. Ramdya, P.; Schneider, J.; Levine, J.D. The neurogenetics of group behavior in Drosophila melanogaster. J. Exp. Biol. 2017, 220, 35–41. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Comparison of human and Drosophila digestive tracts. (a) Digestive tracts of humans and Drosophila. The functional regions of the digestive tract in Drosophila and humans are similar and include esophagus, anterior and posterior midgut (small intestine), large intestine (hindgut), and stomach (crop). (b) Subregions of the Drosophila digestive tract depicting the foregut, midgut, and hindgut. Foregut contains crop and proventriculus. The midgut is further divided into R1-R5 regions. (c) GFP-tagged Lactobacillus was fed to adult Drosophila and confocal images show the distribution of Lactobacillus (green) in different regions of the digestive tract. The magnified images of crop, R2, R4, and R5 regions are showed in c1 to c4. The sample was immunostained with anti-integrin-βPS antibody (red). Scale bar, 500 μm.
Figure 1. Comparison of human and Drosophila digestive tracts. (a) Digestive tracts of humans and Drosophila. The functional regions of the digestive tract in Drosophila and humans are similar and include esophagus, anterior and posterior midgut (small intestine), large intestine (hindgut), and stomach (crop). (b) Subregions of the Drosophila digestive tract depicting the foregut, midgut, and hindgut. Foregut contains crop and proventriculus. The midgut is further divided into R1-R5 regions. (c) GFP-tagged Lactobacillus was fed to adult Drosophila and confocal images show the distribution of Lactobacillus (green) in different regions of the digestive tract. The magnified images of crop, R2, R4, and R5 regions are showed in c1 to c4. The sample was immunostained with anti-integrin-βPS antibody (red). Scale bar, 500 μm.
Biomedicines 10 00596 g001
Table 1. Microbiota related behaviors and neurodegenerative diseases in Drosophila.
Table 1. Microbiota related behaviors and neurodegenerative diseases in Drosophila.
Category Related MicrobiotaReferences
Innate Behavior
Mating behavior
Sperm transferN.D.[31]
FecundityN.D.[32]
Aggressive behavior Acetobacter, Lactobacillus, Enterococcus[33]
Sleep behavior N.D.[34]
Locomotion behavior Lactobacillus brevis[34,35,36]
Temperature tolerance N.D.[37,38]
Learned Behavior
Olfactory memory
Long-term memoryN.D.[34]
Courtship memory
LearningN.D.[34]
Long-term memoryN.D.[34]
Aging
Longevity Lactobacillus plantarum[39,40]
Alzheimer’s disease
elav-Gal4; UAS-BACE/UAS-APP model Kefir related bacteria
Lactobacillus plantarum NCIMB 8826 (Lp8826),
Lactobacillus fermentum NCIMB 5221 (Lf5221),
Bifidobacteria longum spp. infantis NCIMB 702255 (Bi702255)
[41,42]
GMR-Aβ42 model Lactobacillus sakei Probio65, Lactobacillus paracasei 0291
Lactobacillus plantarum DR7, Stenotrophomonas,
Acetobacter, Wolbachia
[43,44]
elav-Gal4; UAS-Aβ42 model Acetobacteraceae, Lactobacillacea, enterobacteria[45,46]
Parkinson disease
elav-Gal4; UAS-Synuclein model Bacteroides ovatu, Eggerthella lenta, Escherichia coli[47]
PINK1 mutant model Proteobacteria, Firmicutes, Bacteroidetes, Acetobacter,
Lactobacillus
[48]
Autism spectrum disorder
kdm5-deficient model Lactobacillus plantarum[49]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chiang, M.-H.; Ho, S.-M.; Wu, H.-Y.; Lin, Y.-C.; Tsai, W.-H.; Wu, T.; Lai, C.-H.; Wu, C.-L. Drosophila Model for Studying Gut Microbiota in Behaviors and Neurodegenerative Diseases. Biomedicines 2022, 10, 596. https://doi.org/10.3390/biomedicines10030596

AMA Style

Chiang M-H, Ho S-M, Wu H-Y, Lin Y-C, Tsai W-H, Wu T, Lai C-H, Wu C-L. Drosophila Model for Studying Gut Microbiota in Behaviors and Neurodegenerative Diseases. Biomedicines. 2022; 10(3):596. https://doi.org/10.3390/biomedicines10030596

Chicago/Turabian Style

Chiang, Meng-Hsuan, Shuk-Man Ho, Hui-Yu Wu, Yu-Chun Lin, Wan-Hua Tsai, Tony Wu, Chih-Ho Lai, and Chia-Lin Wu. 2022. "Drosophila Model for Studying Gut Microbiota in Behaviors and Neurodegenerative Diseases" Biomedicines 10, no. 3: 596. https://doi.org/10.3390/biomedicines10030596

APA Style

Chiang, M. -H., Ho, S. -M., Wu, H. -Y., Lin, Y. -C., Tsai, W. -H., Wu, T., Lai, C. -H., & Wu, C. -L. (2022). Drosophila Model for Studying Gut Microbiota in Behaviors and Neurodegenerative Diseases. Biomedicines, 10(3), 596. https://doi.org/10.3390/biomedicines10030596

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop